Featured Articles
-
Overcoming Gene Therapy Cost Roadblocks On The Path To Patients
7/23/2025
Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.
-
Viral Gene Therapy: Reducing Costs To Improve Patient Access
7/23/2025
Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.
-
Versatile Lipid Nanoparticle Platform For Efficient Gene Editing
6/3/2025
Lipid nanoparticles enable efficient gene editing in hard-to-transfect cells like T-cells and blood stem cells, which offers scalable, clinically relevant methods for developing advanced therapies for cancer and rare diseases.
-
Nanomedicine Modalities Find Path To Clinic Through Analytics
5/16/2025
Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.
-
Cost And Scalability Key Drivers Of Expanded Gene Therapy Access
5/16/2025
Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.
-
Advancing Cell Therapies With Lipid Nanoparticles
3/24/2025
Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
Outsourcing RNA-LNP Production: A Key To Competitive Success
3/6/2025
Manufacturing RNA-containing LNPs demands specialized expertise. Explore some of the challenges of RNA-LNP drug manufacturing and the advantages of outsourcing RNA-LNP formulations.
-
Scaling Up An Upstream Process For Gene Therapies
2/27/2025
It's important to evaluate your starting point when scaling an upstream process. Review key considerations for deciding between adherent and suspension cells to optimize your gene therapy process.
-
Tackling Encapsidated Host Cell DNA To Improve Quality
2/19/2025
Discover a cell line that enhances rAAV production by reducing host cell DNA encapsidation, improving safety and efficiency through genetic modifications that inhibit apoptotic DNA fragmentation.